한글목차

반추동물용 백신 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 31억 9,000만 달러에서 2026년에는 34억 1,000만 달러로, CAGR 6.9%로 확대가 전망되고 있습니다. 지난 수년간의 성장은 가축 질병의 빈번한 발생, 현대 백신에 대한 접근성 제한, 소와 양 사육두수 증가, 가축 건강에 대한 인식 증가, 가축 건강관리 인프라 확충 등이 주요 원인으로 꼽힙니다.

반추동물용 백신 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 44억 달러에 달하며, CAGR은 6.6%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 백신 기술의 발전, 재조합 백신 및 mRNA 백신의 채택 확대, 예방적 가축 헬스케어 프로그램의 성장, 수의학 연구에 대한 투자 증가, 디지털 백신 접종 모니터링 시스템의 통합 등이 있습니다. 예측 기간 중 주요 동향으로는 구제역(FMD) 백신 수요 증가, mRNA 및 DNA 기반 반추동물 백신 채택 확대, 피하 및 근육내 백신 투여 증가, 농장 전체 가축 백신 접종 프로그램 확대, 백신 추적 시스템과 농장 관리 소프트웨어의 통합 등이 있습니다. 백신 추적 시스템과 농장 관리 소프트웨어의 통합 등을 꼽을 수 있습니다.

축산물에 대한 수요 증가는 향후 반추동물 백신 시장의 성장을 촉진할 것으로 예측됩니다. 축산물에는 육류, 우유, 계란, 양모, 가죽 등 가축 유래 제품 외에도 젤라틴, 동물성 유지 등 제품별로 구분됩니다. 이러한 수요는 식습관 변화, 소비자 접근성 확대, 경제성, 경제 발전, 라이프스타일의 변화 등의 요인에 의해 촉진되고 있습니다. 반추동물용 백신은 동물의 건강 증진, 질병 발생 예방, 생산성 향상, 사료 효율 개선, 그리고 육류, 우유 및 기타 제품별 안정적이고 지속가능한 공급을 보장함으로써 축산업을 지원하고 있습니다. 예를 들어 영국 정부 기관인 환경식품농촌지역부(Defra)에 따르면 2025년 10월 기준 2024년 영국 저지대 지역에서 가장 일반적인 농장 형태는 방목형 축산 농장으로 전체 농장의 30%를 차지했다고 합니다. 한편, 곡물 농장은 전체 농지 중 가장 큰 비중을 차지하며 경작지의 33%를 차지했습니다. 따라서 축산물에 대한 수요 증가가 반추동물용 백신 시장을 주도하고 있습니다.

반추동물 백신 시장의 주요 기업은 블루탱고바이러스(BTV) 혈청형 3 백신과 같이 이 바이러스에 대한 효과적인 방어를 제공하는 첨단 제품 개발에 주력하고 있습니다. BTV 혈청형3 백신은 소, 양 등 반추동물의 브루텅게병 예방을 목적으로 설계되었습니다. 예를 들어 2024년 5월 독일에 본사를 둔 바이오 제약기업 베링거인겔하임 인터내셔널(Boehringer Ingelheim International GmbH)은 반추동물용 백신 라인업에 '브루타보3'를 도입했습니다. 이 불활화 백신은 브루타누스 바이러스 혈청형 3에 대한 방어 효과를 제공하고, 바이러스 순환, 사망률, 임상 증상을 크게 감소시킵니다. 이번 제품 출시는 최근 구제역 발생으로 인해 높아진 BTV-3 백신에 대한 긴급한 수요에 대응하여 가축의 건강을 보호하고 농가의 경제적 손실을 줄이는 데 도움이 될 것으로 기대됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Ruminant vaccines are designed to safeguard ruminant animals from a range of infectious diseases. Ruminants, which include animals with a four-compartment stomach (rumen, reticulum, omasum, and abomasum), are herbivores that process fibrous plant material. These vaccines are crucial for maintaining the health, productivity, and welfare of ruminants by preventing diseases such as foot-and-mouth disease, brucellosis, bovine respiratory disease, and clostridial infections.

The primary types of ruminant vaccines include inactivated vaccines, attenuated or modified live vaccines, and others. Inactivated vaccines consist of pathogens that have been killed or inactivated, which helps to elicit an immune response without causing disease. These vaccines are used to protect against various conditions such as bovine respiratory diseases (BRD), diarrhea or scours, foot-and-mouth disease (FMD), clostridial diseases, leptospirosis, and bovine viral diarrhea (BVD) infection. They can be administered via intramuscular, subcutaneous, intranasal, or oral routes. Ruminant vaccines are used for cattle, sheep, and other ruminants, and are typically provided to veterinary hospitals and clinics, livestock farms, and research institutes.

Tariffs have impacted the ruminant vaccines market by increasing the cost of imported vaccines, adjuvants, and cold-chain equipment, particularly affecting inactivated and modified live vaccines. Regions such as Europe and North America, which rely on imported biologics, are most affected. While tariffs increase costs, they also encourage local vaccine production, investment in cost-effective formulations, and development of regionally adapted vaccines for improved disease management.

The ruminant vaccines market research report is one of a series of new reports from The Business Research Company that provides ruminant vaccines market statistics, including ruminant vaccines industry global market size, regional shares, competitors with a ruminant vaccines market share, detailed ruminant vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the ruminant vaccines industry. This ruminant vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ruminant vaccines market size has grown strongly in recent years. It will grow from $3.19 billion in 2025 to $3.41 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to frequent outbreaks of bovine diseases, limited access to modern vaccines, growing cattle and sheep population, rising awareness about livestock health, expansion of veterinary healthcare infrastructure.

The ruminant vaccines market size is expected to see strong growth in the next few years. It will grow to $4.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to advancements in vaccine technologies, increasing adoption of recombinant and mrna vaccines, growth of preventive livestock healthcare programs, rising investment in veterinary research, integration of digital vaccination monitoring systems. Major trends in the forecast period include rising demand for foot-and-mouth disease (fmd) vaccines, increasing adoption of mrna and dna-based ruminant vaccines, growth in subcutaneous and intramuscular vaccine administration, expansion of livestock vaccination programs across farms, integration of vaccination tracking systems with farm management software.

The growing demand for livestock products is expected to drive the growth of the ruminant vaccines market going forward. Livestock products include goods derived from domesticated animals, such as meat, milk, eggs, wool, leather, and by-products like gelatin and animal fats. This demand is driven by factors including changing dietary preferences, increased consumer access, greater affordability, economic development, and evolving lifestyle patterns. Ruminant vaccines support livestock production by improving animal health, preventing disease outbreaks, increasing productivity, enhancing feed efficiency, and ensuring a stable and sustainable supply of meat, milk, and other by-products. For example, in October 2025, according to the Department for Environment Food and Rural Affairs, a UK-based government department, grazing livestock farms were the most common type in lowland areas of England in 2024, accounting for 30% of all farms, while cereal farms occupied the largest share of agricultural land, covering 33% of the total farmed area. Therefore, the rising demand for livestock products is driving the ruminant vaccines market.

Key players in the ruminant vaccines market are focusing on developing advanced products such as the bluetongue virus (BTV) serotype 3 vaccine, which provides effective protection against this virus. The BTV serotype 3 vaccine is designed to prevent bluetongue disease in ruminants such as cattle and sheep. For instance, in May 2024, Boehringer Ingelheim International GmbH, a Germany-based biopharmaceutical company, introduced Bultavo 3 to its ruminant vaccine lineup. This inactivated vaccine offers protection against bluetongue virus serotype 3, significantly reducing virus circulation, mortality, and clinical signs. Its launch addresses the urgent need for a BTV-3 vaccine due to recent outbreaks, helping to safeguard livestock health and reduce economic losses for farmers.

In April 2024, Virbac Group, a France-based animal health products manufacturer, acquired Sasaeah Pharmaceutical Co. Ltd. for an undisclosed amount. This acquisition aims to strengthen Virbac's position in the Japanese livestock vaccine market, particularly for cattle, by leveraging Sasaeah's established production facilities, extensive R&D capabilities, and broad pharmaceutical portfolio. This move supports Virbac's strategic growth and expansion in the animal health sector. Sasaeah Pharmaceutical Co. Ltd., based in Japan, specializes in manufacturing ruminant vaccines.

Major companies operating in the ruminant vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Inc., Ceva Sante Animale, Virbac, Phibro Animal Health Corporation, Vetoquinol S.A., Indian Immunologicals Ltd., Anicon Labor GmbH (SAN Group), IDT Biologika GmbH, Jinyu Bio-Technology Co. Ltd., Vaxxinova International B.V., Biogenesis Bago S.A, CZ Vaccines, Hester Biosciences Limited, Choong Ang Vaccine Laboratories Co. Ltd., Hipra Corporations, VETVACO National Veterinary Joint Stock Company, Kyoto Biken Laboratories Inc., Fatro Spa

North America was the largest region in the ruminant vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ruminant vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ruminant vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The ruminant vaccines market consists of sales of brucellosis vaccines, bluetongue virus vaccines, E. coli vaccines, mycoplasma vaccines, and chlamydia vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ruminant Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ruminant vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ruminant vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ruminant vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Vaccine Type: Inactivated Vaccines; Attenuated Or Modified Live Vaccines; Other Vaccine Types
• 2) By Indication: Bovine Respiratory Diseases (BRD); Diarrhea Or Scours; Foot-and-Mouth Disease (FMD); Clostridial Diseases; Leptospirosis; Bovine Viral Diarrhea (BVD) Infection; Other Indications
• 3) By Route Of Administration: Intramuscular; Subcutaneous; Intranasal; Oral
• 4) By Application: Cattle; Sheep; Other Applications
• 5) By End-User: Veterinary Hospitals And Clinics; Livestock Farms; Research Institutes
• Subsegments:
• 1) By Inactivated Vaccines: Killed Virus Vaccines; Bacterial Inactivated Vaccines; Subunit Vaccines
• 2) By Attenuated Or Modified Live Vaccines: Live Attenuated Virus Vaccines; Live Bacterial Vaccines; Recombinant Live Vaccines
• 3) By Other Vaccine Types: DNA Vaccines; mRNA Vaccines; Viral Vector Vaccines
• Companies Mentioned: Boehringer Ingelheim International GmbH; Zoetis Inc.; Merck & Co. Inc.; Elanco Animal Health Inc.; Ceva Sante Animale; Virbac; Phibro Animal Health Corporation; Vetoquinol S.A.; Indian Immunologicals Ltd.; Anicon Labor GmbH (SAN Group); IDT Biologika GmbH; Jinyu Bio-Technology Co. Ltd.; Vaxxinova International B.V.; Biogenesis Bago S.A; CZ Vaccines; Hester Biosciences Limited; Choong Ang Vaccine Laboratories Co. Ltd.; Hipra Corporations; VETVACO National Veterinary Joint Stock Company; Kyoto Biken Laboratories Inc.; Fatro Spa
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Ruminant Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Ruminant Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Ruminant Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Ruminant Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Biotechnology, Genomics & Precision Medicine
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Foot-And-Mouth Disease (Fmd) Vaccines
  • 4.2.2 Increasing Adoption Of Mrna And Dna-Based Ruminant Vaccines
  • 4.2.3 Growth In Subcutaneous And Intramuscular Vaccine Administration
  • 4.2.4 Expansion Of Livestock Vaccination Programs Across Farms
  • 4.2.5 Integration Of Vaccination Tracking Systems With Farm Management Software

5. Ruminant Vaccines Market Analysis Of End Use Industries

• 5.1 Veterinary Hospitals And Clinics
• 5.2 Livestock Farms
• 5.3 Research Institutes
• 5.4 Animal Health Service Providers
• 5.5 Government Veterinary Departments

6. Ruminant Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ruminant Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Ruminant Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Ruminant Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Ruminant Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Ruminant Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ruminant Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ruminant Vaccines Market Segmentation

• 9.1. Global Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inactivated Vaccines, Attenuated Or Modified Live Vaccines, Other Vaccine Types
• 9.2. Global Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bovine Respiratory Diseases (BRD), Diarrhea Or Scours, Foot-and-Mouth Disease (FMD), Clostridial Diseases, Leptospirosis, Bovine Viral Diarrhea (BVD) Infection, Other Indications
• 9.3. Global Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Intramuscular, Subcutaneous, Intranasal, Oral
• 9.4. Global Ruminant Vaccines Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cattle, Sheep, Other Applications
• 9.5. Global Ruminant Vaccines Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Veterinary Hospitals And Clinics, Livestock Farms, Research Institutes
• 9.6. Global Ruminant Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Killed Virus Vaccines, Bacterial Inactivated Vaccines, Subunit Vaccines
• 9.7. Global Ruminant Vaccines Market, Sub-Segmentation Of Attenuated Or Modified Live Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Virus Vaccines, Live Bacterial Vaccines, Recombinant Live Vaccines
• 9.8. Global Ruminant Vaccines Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• DNA Vaccines, mRNA Vaccines, Viral Vector Vaccines

10. Ruminant Vaccines Market Regional And Country Analysis

• 10.1. Global Ruminant Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Ruminant Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ruminant Vaccines Market

• 11.1. Asia-Pacific Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ruminant Vaccines Market

• 12.1. China Ruminant Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ruminant Vaccines Market

• 13.1. India Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ruminant Vaccines Market

• 14.1. Japan Ruminant Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ruminant Vaccines Market

• 15.1. Australia Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ruminant Vaccines Market

• 16.1. Indonesia Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ruminant Vaccines Market

• 17.1. South Korea Ruminant Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ruminant Vaccines Market

• 18.1. Taiwan Ruminant Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ruminant Vaccines Market

• 19.1. South East Asia Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ruminant Vaccines Market

• 20.1. Western Europe Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ruminant Vaccines Market

• 21.1. UK Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ruminant Vaccines Market

• 22.1. Germany Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ruminant Vaccines Market

• 23.1. France Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ruminant Vaccines Market

• 24.1. Italy Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ruminant Vaccines Market

• 25.1. Spain Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ruminant Vaccines Market

• 26.1. Eastern Europe Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ruminant Vaccines Market

• 27.1. Russia Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ruminant Vaccines Market

• 28.1. North America Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ruminant Vaccines Market

• 29.1. USA Ruminant Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ruminant Vaccines Market

• 30.1. Canada Ruminant Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ruminant Vaccines Market

• 31.1. South America Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ruminant Vaccines Market

• 32.1. Brazil Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ruminant Vaccines Market

• 33.1. Middle East Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ruminant Vaccines Market

• 34.1. Africa Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Ruminant Vaccines Market, Segmentation By Vaccine Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ruminant Vaccines Market Regulatory and Investment Landscape

36. Ruminant Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Ruminant Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Ruminant Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Ruminant Vaccines Market Company Profiles
  • 36.3.1. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

37. Ruminant Vaccines Market Other Major And Innovative Companies

• Virbac, Phibro Animal Health Corporation, Vetoquinol S.A., Indian Immunologicals Ltd., Anicon Labor GmbH (SAN Group), IDT Biologika GmbH, Jinyu Bio-Technology Co. Ltd., Vaxxinova International B.V., Biogenesis Bago S.A, CZ Vaccines, Hester Biosciences Limited, Choong Ang Vaccine Laboratories Co. Ltd., Hipra Corporations, VETVACO National Veterinary Joint Stock Company, Kyoto Biken Laboratories Inc.

38. Global Ruminant Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ruminant Vaccines Market

40. Ruminant Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Ruminant Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Ruminant Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Ruminant Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer